Japan Respiratory Disease Market Outlook to 2013 Emerging Opportunities

This report presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies Reviews features and operating characteristics of major analyzers used for microbiology testing; Profiles key suppliers and potential market entrants developing innovative technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Request your sample copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=68983

Buy Your Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=68983

Table Of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests
1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers

C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

VI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market Shares

Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

Competitive Assessments

List of Tables

Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests Japan
Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Influenza Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Legionella Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Legionella Testing Market Diagnostics Sales Forecast by Major Supplier Japan
Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Mononucleosis Testing Market Diagnostics Sales by Major Supplier Japan
Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Mycoplasma Testing Market Diagnostics Sales by Major Supplier Japan
Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Pneumonia Testing Market Diagnostics Sales by Major Supplier Japan
RSV Test Volume and Diagnostics Sales Forecast by Market Segment Japan
RSV Testing Market Diagnostics Sales by Major Supplier Japan
Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Tuberculosis Testing Market Diagnostics Sales by Major Supplier

Filed in: Diagnostics, Medical Device
More Reports
Title Price Buy Now

Global In-vitro Toxicity Testing Market 2014-2018

In vitro literally means in glass, and refers to procedures or tests carried out under a defined set of experimental conditions and not on living beings. In vitro toxicity testing is the analysis of adverse effects of toxic chemical or biological substances on cultured cells. All pharmaceutical, chemical, or cosmetic products have to undergo rigorous toxicity testing before they are marketed, to ensure safe usage. Toxicity tests are conducted to test the effect of the product or ingredients on organs or body systems. Many in vitro toxicity tests utilize yeast, bacterial, mammalian or human cell cultures, tissue slices, and subcultures to test for toxicity, ocular irritation, and skin corrosion/irritation. TechNavio's analysts forecast the Global In Vitro Toxicity Testing market will gro......
$2500

Global Companion Diagnostics Market 2014-2018

About Companion Diagnostics Companion diagnostics is used to identify suitable patients to whom specific drugs can be administered and it monitors the prognosis of the effects of the drug(s) on the disease. This concept of combining a drug with a diagnostic test is termed predictive medicine or personalized medicine. The companion diagnostic test has the ability to predict disease risk, diagnose disease, and monitor the therapeutic response. The tests enable physicians to make informed decisions on the type of drugs to use and the dosage in order to attempt to reduce the mortality rate of diseases such as cancer and neurodegenerative disorders. TechNavio's analysts forecast the Global Companion Diagnostics market will grow at a CAGR of 18.59 percent over the period 2013-2018. Cove......
$2500

Global Enteric Disease Testing Market 2014-2018

TechNavio's analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric diseases. The Global Enteric Disease Testing market has also been witnessing the emergence of new pathogens causing infections. However, the stringent regulatory approval could pose a challenge to the growth of this market. TechNavio's report, the Global Enteric Disease Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Enteric Disease Testing market landscape and its growth prospects in the coming years. The ......
$2500

Prenatal Testing Market in the US 2014-2018

TechNavio's analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market. TechNavio's report, the Prenatal Testing Market in the US 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the US; it also covers the Prenatal Testing market landscape and its growth prospects in the coming years. The report also includes a discussion o......
$2500

Global Glycated Hemoglobin Testing Market 2012-2016

TechNavio's analysts forecast the Global Glycated Hemoglobin Testing market to grow at a CAGR of 10.10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of diabetes. The Global Glycated Hemoglobin Testing market has also been witnessing the growing use of point of care hemoglobin A1c testing. However, the presence of substitutes could pose a challenge to the growth of this market. TechNavio's report, the Global Glycated Hemoglobin Testing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Glycated Hemoglobin Testing market landscape and its growth prospects in the coming ye......
$2500

Global Vitamin D Testing Market 2014-2018

TechNavio's analysts forecast the Global Vitamin D Testing Market to grow at a CAGR of 32.36 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in aging and chronically ill populations worldwide. The Global Vitamin D Testing Market has also been witnessing the increase in product approvals. However, the stringent regulatory requirements could pose a challenge to the growth of this market. TechNavio's report, the Global Vitamin D Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA and APAC regions; it also covers the Global Vitamin D Testing market landscape and its growth prospects in the coming years. The report also includes a discu......
$2500

Global Positron Emission Tomography Market 2012-2016

TechNavio's analysts forecast the Global Positron Emission Tomography market to grow at a CAGR of 3.74 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global PET market has also been witnessing the fusion of PET with other modalities. However, the negative impact of the economic recession could pose a challenge to the growth of this market. TechNavio's report, the Global PET Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global PET market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operatin......
$2500

Global In Vitro Fertilization Market 2012-2016

TechNavio's analysts forecast the Global In Vitro Fertilization (IVF) market to grow at a CAGR of 12.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high prevalence of infertility rates. The Global IVF market has also been witnessing the increase in medical tourism. However, the high cost associated with the IVF procedures could pose a challenge to the growth of this market. TechNavio's report, Global IVF Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global IVF market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in......
$2500

Therapeutics Market: Type 2 Diabetes Industry 2019 Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019

The report “Type 2 Diabetes Market to 2019 – A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019” by GBI Research is now available at RnRMarketResearch.com.com. Contact sales@rnrmarketresearch.com with report name in subject line and your contact details to purchase this report or get your questions answered. “Type 2 Diabetes Market to 2019 – A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019”. There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012 to 2019, th......
$

CR and DR Market in the US 2012-2016

TechNavio's analysts forecast the Computed Radiography (CR) and Digital Radiography (DR) market in the US to grow at a CAGR of 2.62 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in technological innovations. The CR and DR market in the US has also been witnessing an increasing use of CR in mammography. However, intense competition among vendors could pose a challenge to the growth of this market. TechNavio's report, the CR and DR Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the CR and DR market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this ma......
$2500